Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Hall

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Biochemical Pharmacology|January 22, 1992
Purification of the human blood platelet thromboxane A2/prostaglandin H2 receptor proteinS O Kim, C T Lim, S C Lam, et al.
Prostaglandins|April 1, 1986
Inhibition of prostaglandin biosynthesis by SQ 28,852, a 7-oxabicyclo[2.2.1]heptane analogD N Harris, M B Phillips, I M Michel, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 12, 1999
Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-IC R Bangham, S E Hall, K J Jeffery, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1992
Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factorK E Coyne, S E Hall, S Thompson, et al.
Journal of Medicinal Chemistry|June 1, 1990
9,11-epoxy-9-homoprosta-5-enoic acid analogues as thromboxane A2 receptor antagonistsJ Das, S E Hall, M Nakane, et al.
Journal of Medicinal Chemistry|May 14, 1993
Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonistsR N Misra, B R Brown, P M Sher, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1992
Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552D N Harris, I M Michel, H J Goldenberg, et al.
Journal of Virology|November 13, 1999
Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathyG P Taylor, S E Hall, S Navarrete, et al.
Journal of Medicinal Chemistry|January 17, 1997
Synthesis and protein kinase C inhibitory activities of balanol analogs with replacement of the perhydroazepine moietyY S Lai, J S Mendoza, G E Jagdmann, et al.
Journal of Medicinal Chemistry|December 20, 1996
Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase AJ M Defauw, M M Murphy, G E Jagdmann, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Biochemical Pharmacology|January 22, 1992
Purification of the human blood platelet thromboxane A2/prostaglandin H2 receptor proteinS O Kim, C T Lim, S C Lam, et al.
Prostaglandins|April 1, 1986
Inhibition of prostaglandin biosynthesis by SQ 28,852, a 7-oxabicyclo[2.2.1]heptane analogD N Harris, M B Phillips, I M Michel, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 12, 1999
Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-IC R Bangham, S E Hall, K J Jeffery, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1992
Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factorK E Coyne, S E Hall, S Thompson, et al.
Journal of Medicinal Chemistry|June 1, 1990
9,11-epoxy-9-homoprosta-5-enoic acid analogues as thromboxane A2 receptor antagonistsJ Das, S E Hall, M Nakane, et al.
Journal of Medicinal Chemistry|May 14, 1993
Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonistsR N Misra, B R Brown, P M Sher, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1992
Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552D N Harris, I M Michel, H J Goldenberg, et al.
Journal of Virology|November 13, 1999
Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathyG P Taylor, S E Hall, S Navarrete, et al.
Journal of Medicinal Chemistry|January 17, 1997
Synthesis and protein kinase C inhibitory activities of balanol analogs with replacement of the perhydroazepine moietyY S Lai, J S Mendoza, G E Jagdmann, et al.
Journal of Medicinal Chemistry|December 20, 1996
Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase AJ M Defauw, M M Murphy, G E Jagdmann, et al.
Pageof 10